Screening compound: NAIMCEFAGOEXSH-UHFFFAOYSA-N

Screening compound: NAIMCEFAGOEXSH-UHFFFAOYSA-N
Screening compound: NAIMCEFAGOEXSH-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
NAIMCEFAGOEXSH-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

N025-0034

Molecular Formula

C48H78O18 (C48 H78 O18)

Compound Name

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate

IUPAC name

345-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-{[34-dihydroxy-6-(hydroxymethyl)-5-{[345-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-226a6b9912a-heptamethyl-12344a566a6b788a910111212a12b1314b-icosahydropicene-4a-carboxylate

SMILES

CC(C)(CC1)CC2C3=CCC(C(C)(CC4)C(CC5)C(C)(C)C4OC(C(C4O)O)OC(CO)C4OC(C(C4O)O)OC(CO)C4O)C5(C)C3(C)CCC12C(OC(C(C1O)O)OC(CO)C1O)=O

InChI

InChI=1S/C48H78O18/c1-43(2)14-16-48(42(60)66-41-36(58)33(55)31(53)25(20-50)62-41)17-15-46(6)22(23(48)18-43)8-9-28-45(5)12-11-29(44(3,4)27(45)10-13-47(28,46)7)64-39-37(59)34(56)38(26(21-51)63-39)65-40-35(57)32(54)30(52)24(19-49)61-40/h8,23-41,49-59H,9-21H2,1-7H3

InChI Key

NAIMCEFAGOEXSH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00808529

NAIMCEFAGOEXSH-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Glucocorticoid receptors Library (4806 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Natural Compounds Library (353 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Targets:
  • Nuclear receptors
  • Phosphatases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with NAIMCEFAGOEXSH-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound NAIMCEFAGOEXSH-UHFFFAOYSA-N?
Check Price and Availability of NAIMCEFAGOEXSH-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of NAIMCEFAGOEXSH-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for NAIMCEFAGOEXSH-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for NAIMCEFAGOEXSH-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of NAIMCEFAGOEXSH-UHFFFAOYSA-N available by request